Acme United (ACU) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record net sales of $194.5 million and record EBITDA of $20 million for 2024, with net income rising 23% year-over-year to $10 million.
Sold Cuda and Camillus hunting and fishing business in November 2023 for $19.8 million, using $15 million after-tax proceeds to reduce debt and support growth.
Adjusted net revenues (excluding divested businesses) grew 6% in 2024; overall net sales grew 2% despite $9 million revenue loss from divestiture.
Elite First Aid acquisition in May 2024 for $6.1 million was fully integrated, supporting growth in first responder kits.
Productivity improvements and cost reductions offset lost contributions from divested businesses.
Financial highlights
Fourth quarter net sales were $45.9 million, up 10% year-over-year; full-year net sales reached $194.5 million, up 2%.
Gross margin for 2024 was 39.3%, up from 37.7% in 2023, driven by productivity improvements.
SG&A expenses for 2024 were $62 million (32% of sales), up from $59 million (31% of sales) in 2023, mainly due to inflation and wage increases.
Interest expense declined to $1.9 million from $3 million in 2023, reflecting lower average debt.
Earnings per share for 2024 were $2.45, up 10% from $2.23 in 2023.
Outlook and guidance
Management expects further growth in 2025, leveraging strong liquidity, customer base, and the Elite First Aid acquisition.
SG&A expected to remain between 31% and 32% of sales going forward.
Company anticipates challenges from tariffs in 2025 but feels well-prepared due to diversified sourcing and domestic production.
Plans to expand distribution and sales of first responder kits and pursue additional acquisitions.
Latest events from Acme United
- Q2 sales up 16% to $62.7M, net income up 6%, with margin gains and broad-based growth.ACU
Q2 202623 Jul 2026 - Q2 net income up 29% on higher sales and margin, with Elite First Aid acquisition completed.ACU
Q2 20249 Jul 2026 - Q1 2025 sales and EPS rose on first-aid strength, despite tariff and supply chain headwinds.ACU
Q1 20258 Jul 2026 - First aid and safety drive growth, targeting $300M revenue in three years with global expansion.ACU
Sidoti Micro-Cap Virtual Conference20 May 2026 - Innovation and acquisitions fuel robust growth in sales, earnings, and market expansion.ACU
Investor presentation20 May 2026 - Q1 2026 sales up 14%, but net income down 40% as higher costs and tariffs offset gains.ACU
Q1 20266 May 2026 - All proposals, including board elections and stock plan amendments, were approved by majority vote.ACU
AGM 202628 Apr 2026 - Shareholders will vote on director elections, stock option plan expansion, executive pay, and auditor ratification.ACU
Proxy filing27 Mar 2026 - Record 2025 results and Q4 growth, with acquisitions and investments fueling future expansion.ACU
Q4 202527 Feb 2026